Return to content in this issue

Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis

Freemantle N¹, Piketty C<sup>2

1</sup>Institute of Clinical Trials and Methodology, University College London, London, UK
²Galderma, Lausanne, Switzerland

J Investig Allergol Clin Immunol 2021; Vol 31(6) : 528-529
doi: 10.18176/jiaci.0727